TRADE REMEDIES | 2026-05-28
Section 232 Pharmaceutical Tariffs on Patented Drugs: What California Importers, Biotech Firms, and Health Systems Need to Know (May 2026)
The April 2, 2026 presidential proclamation imposing a 100 percent tariff on branded drugs and their ingredients reshapes the compliance landscape for California pharmaceutical importers.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
On April 2, 2026, President Trump issued a presidential proclamation under Section 232 of the Trade Expansion Act of 1962 imposing a 100 percent tariff on certain patented pharmaceuticals together with their associated active pharmaceutical ingredients and key starting materials. The proclamation followed a Commerce Department national-security investigation into the nation's dependence on imported drugs and drug ingredients. Generic drugs are carved out for now, and the effective dates are stag
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301